ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 572

Radiographic Damage in Ankylosing Spondylitis Over 12 Years of Follow-up: A Longitudinal Analysis

Sofia Ramiro1, Carmen Stolwijk2, A.M. Van Tubergen3, Désirée van der Heijde4 and Robert Landewé5, 1Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam, The Netherlands and Hospital Garcia de Orta, Almada, Portugal, 2Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 3Department of Medicine, Maastricht University Medical Center, Maastricht, Netherlands, 4Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Heerlen, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: imaging techniques, Outcome measures and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose: Radiographic damage is one of the core outcomes recommended by the Assessment in Spondyloarthritis international Society (ASAS) for follow-up of patients with axial SpA. So far, the evolution of radiographic damage over a long period has not been described in detail. We aimed to describe the evolution of radiographic abnormalities over time in a prevalence cohort of patients with ankylosing spondylitis (AS).

 Methods: The modified Stoke AS Spine Score (mSASSS) was calculated using 2-yearly radiographs of patients followed for 12 years in the Outcome in AS International Study (OASIS). Two readers independently scored the x-rays and scores were averaged. Status and progression scores (2- and 12-year-progression) were computed for patients with at least one 2-year interval available (n=186) and for those with an mSASSS at 12-years (n=68). New syndesmophytes at vertebral corners (VCs) “at risk” (i.e. without a previous syndesmophyte or bridge) were computed. Radiographic progression over time was investigated using generalized estimating equations. Relevant interactions with time were explored. Time was modeled in different forms (linear and non-linear) and the best model fit was assessed using the quasi-likelihood information criterion.

 Results: 809 radiographs of 186 patients (70% males, mean (SD) age 43(12) years, mean disease duration 11.0(8.8) years and 83% HLA-B27 positive) were included. The mean (SD) mSASSS at baseline was 11.6 (16.2) [11.2 (15.7) in patients with mSASSS at 12-years]. The mean (SD) 2-year interval progression score (in 520 2-year intervals) was 2.0 (3.5) [2.2 (3.9) for the subset of 12-year-completers]. Over the 12 years, the mean (SD) progression was 11.7 (11.5). A new syndesmophyte was assessed in 38% by one reader (R1) and 39% by reader 2 of all 2-year intervals and, throughout follow-up, in 55% (R1) and 63% (R2) of the patients with at least one VC “at risk”. In 24% of the patients (39% of the 2-year intervals) there was no progression in mSASSS. A progression ≥1 mSASSS occurred in 72% of the patients (54% of the intervals) and a progression ≥5 mSASSS in 22% of the patients (12% of the intervals). At the group level, a linear time course model fitted the observed data the best. Time was positively associated with radiographic progression, with an increase of 0.98 mSASSS/year (≈1.96 mSASSS in 2 years) (Table). Radiographic progression occurred significantly faster in males (vs females) and in HLA-B27 positive patients (vs HLA-B27 negative). HLA-B27 positive male (but not female) patients had a significantly higher progression than HLA-B27 negative males. Progression was independent of disease- and symptom duration.

Conclusion: Long-term radiographic progression in AS is more severe in HLA-B27-positive males. About 60% of all patients have at least one new syndesmophyte. Radiographic progression is dependent on time and, at the group level, linear.

Table – Progression of radiographic damage over time

 

Univariable regression analysis

Β (95% CI)

P-value

Time (years)

0.98 (0.84; 1.12)

<0.001

Time X HLAB27

 

0.052

–       Time in HLAB27 negative

0.70 (0.48; 0.90)

<0.001

–       Time in HLAB27 positive

1.03 (0.88; 1.19)

<0.001

Time X gender

 

0.005

–       Time in women

0.69 (0.57; 0.80)

<0.001

–       Time in men

1.11 (0.93; 1.29)

<0.001

Time X HLAB27 in women

 

0.958

Time X HLAB27 in men

 

0.044

–       Time in female HLAB27 positive

0.69 (0.34; 1.03)

<0.001

–       Time in male HLAB27 positive

1.18 (0.98; 1.38)

<0.001

Time X disease duration

 

0.701

Time X symptom duration

 

0.214


Disclosure:

S. Ramiro,
None;

C. Stolwijk,
None;

A. M. Van Tubergen,
None;

D. van der Heijde,
None;

R. Landewé,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/radiographic-damage-in-ankylosing-spondylitis-over-12-years-of-follow-up-a-longitudinal-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology